戻る
Actavia Life Sciences Inc (RASP)価格
RASP 株価推移チャート
RASP 財務
Actavia Life Sciences Inc
$0
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.0005
始値
$0.0004
当日レンジ
$0.0004 - $0.0005
52週レンジ
$0.0004 - $0.004
取引高
20
平均取引高
322
1株当たり利益(TTM)
-0.00
配当利回り
--
時価総額
$385.9K
RASPとは何ですか？
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The company went IPO on 2014-03-28. The firm is engaged in developing therapeutics to address the unmet need that exists for acute myeloid leukemia (AML), and other forms of leukemia and lymphoma. AML is generally a disease of older adults. The company develops small molecule drug candidates targeting the LSD1 gene, which controls pathways underlying the etiology of AML subtypes. Its RASP-201 is a novel, orally dosed, selective reversible inhibitor of lysine specific demethylase (LSD1), a pathway that blocks differentiation and confers a poor prognosis to AML. RASP-201 when dosed orally shows in vivo therapeutic utility in murine (mouse) models of AML. Its primary indication is AML which may be fatal within weeks to months.